Citizens Financial Group’s CervoMed CRVO Stock Holding History

Citizens Financial Group’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$148K	Hold	37,477	–	–	﹤0.01%	816
2025 Q4	$296K	Buy	37,477 +7,000	+23%	+$56.2K	﹤0.01%	660
2025 Q3	$247K	Buy	30,477 +3,800	+14%	+$32.6K	﹤0.01%	707
2025 Q2	$168K	Hold	26,677	–	–	﹤0.01%	676
2025 Q1	$244K	Buy	+26,677	New	+$102K	﹤0.01%	545
2024 Q4	–	Sell	-30,509	Closed	-$445K	–	590
2024 Q3	$445K	Buy	30,509 +3,553	+13%	+$55.1K	0.01%	396
2024 Q2	$461K	Buy	+26,956	New	+$589K	0.01%	381

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Citizens Financial Group's CRVO Position: Q1 2026 in Review

Citizens Financial Group held its CervoMed (CRVO) position steady in Q1 2026 at 37,477 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Citizens Financial Group first reported a position in CRVO in Q2 2024 and has held it in 7 quarters since. The position peaked at $461K in Q2 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

Citizens Financial Group held 37,477 shares of CervoMed worth $148K as of Q1 2026.
Citizens Financial Group left its CervoMed share count unchanged in Q1 2026.
CervoMed made up ﹤0.01% of Citizens Financial Group's portfolio in Q1 2026, its #816 holding.
Citizens Financial Group first reported a position in CervoMed in Q2 2024 and has held it in 7 quarters since.
Citizens Financial Group's CervoMed position peaked at $461K in Q2 2024.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.